ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Director Defends Goal to Eliminate Suffering, Death From Cancer by 2015

June 13, 2003

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

Survival Of Control Programs After NCI Money Runs Out Developing Into A Worrisome Issue

June 1, 1975

In Brief: Contract Vs. Grants A Non-Issue, Upton Says In Farewell Appearance; Conte Eyes Chairmanship

January 18, 1980

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980